Laser-Assisted Versus Conventional Intracytoplasmic Sperm Injection

Sponsor
Shady Grove Fertility Reproductive Science Center (Other)
Overall Status
Completed
CT.gov ID
NCT00114725
Collaborator
(none)
60
1
7
8.5

Study Details

Study Description

Brief Summary

Laser-assisted intracytoplasmic sperm injection (ICSI) has been suggested as a more effective alterative to conventional ICSI when this method of insemination is indicated for patients undergoing in vitro fertilization (IVF). Laser-assisted ICSI differs from conventional ICSI in that a laser is used to drill a small hole through the hard outer coating surrounding an egg before the injection needle containing a single sperm is inserted into the egg. The hole eliminates compression of the egg that normally occurs with conventional ICSI, and thus may reduce the chance of damage. Laser-assisted ICSI is hypothesized to result in increased egg survival, and perhaps improved embryo quality, compared to conventional ICSI.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Laser-assisted intracytoplasmic sperm injection
N/A

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Laser-Assisted Versus Conventional Intracytoplasmic Sperm Injection
Study Start Date :
Mar 1, 2004
Study Completion Date :
Oct 1, 2004

Outcome Measures

Primary Outcome Measures

  1. oocyte survival rate 1 day after ICSI []

Secondary Outcome Measures

  1. normal fertilization rate 1 day after ICSI []

  2. embryo cell numbers 2 and 3 days after ICSI []

  3. embryo fragmentation rates 2 and 3 days after ICSI []

  4. embryo compaction rate through day 7 after ICSI []

  5. blastocyst formation rate through day 7 after ICSI []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of infertility

  • Scheduled for IVF with ICSI

Exclusion Criteria:
  • Retrieval of fewer than 6 mature oocytes

Contacts and Locations

Locations

Site City State Country Postal Code
1 Shady Grove Fertility Reproductive Science Center Rockville Maryland United States 20850

Sponsors and Collaborators

  • Shady Grove Fertility Reproductive Science Center

Investigators

  • Principal Investigator: Alana Davis, BS, Shady Grove Fertility Reproductive Science Center
  • Study Director: Kevin S Richter, PhD, Shady Grove Fertility Reproductive Science Center

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00114725
Other Study ID Numbers:
  • P2004-1
First Posted:
Jun 17, 2005
Last Update Posted:
Jun 24, 2005
Last Verified:
Jun 1, 2005

Study Results

No Results Posted as of Jun 24, 2005